Khaled Aref Hassan

机构：Cleveland Clinic · ORCID：0000-0001-5553-5051

发表论文 156 篇 · 总被引 3325 次 · h-index 24

代表论文

• Management of Pulmonary Toxicities Associated with Systemic Therapy in Non Small Cell Lung Cancer (2024 · Current Treatment Options in Oncology · 被引 17)
• Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab (2023 · Clinical Lung Cancer · 被引 14)
• Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study (2025 · Lung Cancer · 被引 3)
• MUC1-C: The Occam Razor of Osimertinib Resistance? (2024 · Journal of Thoracic Oncology · 被引 3)
• Role of EGFR-TKIs in Nonmetastatic Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Comprehensive Review (2026 · JCO Oncology Practice · 被引 1)
• Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC) (2025 · Clinical Lung Cancer · 被引 1)